5 Steps to prevent Heart Disease

Tuesday, November 12, 2013

CIMT used to track atheroma in carotids

Carotid Intima-Media Thickness in Children With Familial Hypercholesterolemia

  1. Barbara A. Hutten
+ Author Affiliations
  1. From the Departments of Vascular Medicine (D.M.K., J.J.P.K.), Pediatrics (D.M.K., A.W.), and Clinical Epidemiology, Biostatistics, and Bioinformatics (B.A.H.), Academic Medical Center, Amsterdam, the Netherlands.
  1. Correspondence to Barbara A. Hutten, PhD, Academic Medical Center, Department of Clinical Epidemiology, Biostatistics, and Bioinformatics, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands. E-mail b.a.hutten@amc.uva.nl


Rationale: Familial hypercholesterolemia (FH) predisposes patients to premature cardiovascular disease, with the process of atherosclerosis initiated in early childhood.
Objective: As part of an ongoing trial to assess the efficacy and safety of rosuvastatin in children with FH aged 6 to 17 years, we report the differences in carotid intima-media thickness (cIMT) at baseline between children with FH and their unaffected siblings.
Methods and Results: B-mode ultrasound measurements of the carotid artery were made in 196 children with FH and 64 of their siblings. Mean (±SE) cIMT in children with FH was significantly greater than that of unaffected siblings (0.398±0.052 versus 0.377±0.045 mm; P<0 .001="" 8="" a="" age="" analyses="" and="" before="" cimt.="" cimt="" fh="" greater="" independent="" male="" multivariable="" observed="" of="" p="" predictors="" presence="" sex="" showed="" significantly="" that="" the="" value="" was="" were="" years.="">

 The difference in mean cIMT between children with FH and their unaffected siblings may be significant as early as age 8 years.
 This study confirms the need for early cholesterol lowering in this high-risk population. 
These patients participating in a carefully monitored study will help assess the long-term efficacy on cIMT and safety of statin therapy in young children.